相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015
Etienne Puymirat et al.
AMERICAN HEART JOURNAL (2019)
Renal Failure Impact on the Outcomes of ST-Segment Elevation Myocardial Infarction Patients Due to a Left Main Coronary Culprit Lesion Treated Using a Primary Percutaneous Coronary Intervention
Calin Homorodean et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics
Luc Rochette et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
Post-Infectious Myocardial Infarction: New Insights for Improved Screening
Alain Putot et al.
JOURNAL OF CLINICAL MEDICINE (2019)
TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction
Guan-Lin Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study
Jing-Jing Xu et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease
Taiwu Lin et al.
ANGIOLOGY (2018)
The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
Luc Rochette et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Coronary Artery Calcification From Mechanism to Molecular Imaging
Takehiro Nakahara et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene
Yilin Hao et al.
CARDIOVASCULAR RESEARCH (2016)
Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL
Emma Harper et al.
VASCULAR PHARMACOLOGY (2016)
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease
Taichirou Morisawa et al.
INTERNATIONAL HEART JOURNAL (2015)
Influence of pre-analytical and analytical factors on osteoprotegerin measurements
C. Perez de Ciriza et al.
CLINICAL BIOCHEMISTRY (2014)
The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography
Samad Ghaffari et al.
CARDIOLOGY JOURNAL (2013)
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromso Study
A. Vik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease
S. Jono et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients
Marion Morena et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Relation of osteoprotegerin to coronary calcium and aortic plaque (from The Dallas Heart Study)
Moeen Abedin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase
AP Kappetein et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
S Kiechl et al.
CIRCULATION (2004)
Increased osteoprotegerin serum levels in men with coronary artery disease
M Schoppet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
M Schoppet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
LC Hofbauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
